NEW YORK (GenomeWeb News) – Luminex has extended a credit agreement with JP Morgan Chase Bank from last year through February 26, 2009, and has increased the tangible net worth Luminex must maintain to $35 million, according to a filing with the US Securities and Exchange Commission.
 
The agreement extends a credit facility entered into in March 2007, under which the company may borrow up to $15 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.